Resurgence in COVID Infections Across the Americas 14/07/2021 Raisa Santos Though new COVID-19 cases are down nearly 20% from last week in the Americas, many countries are experiencing a resurgence in infections, officials from the Pan American Health Organization (PAHO) announced at a press briefing on Wednesday. Over 962,280 new cases were reported in the region in the past week, according to data from the […] Continue reading -> A New Partnership to Help Eliminate Complex and Persistent Malaria Vivax 14/07/2021 Chandre Prince Ethiopia, India, Indonesia, Papua New Guinea and Peru are set to benefit from a US$ 25 million investment by Unitaid into a new Partnership For Vivax Elimination (PAVE), which aims to help these countries eliminate Plasmodium vivax (P. Vivax) malaria. PAVE will also generate and consolidate evidence to support malaria-endemic countries in developing and implementing […] Continue reading -> Scale Up of Sputnik V Vaccine Production Through Agreement with Serum Institute 13/07/2021 Madeleine Hoecklin The Serum Institute of India (SII), the world’s largest vaccine manufacturer, is set to begin producing Russia’s Sputnik V COVID-19 vaccine in September, paving the way to scale up globally available COVID vaccines. The Sputnik V vaccine, produced by Moscow’s Gamaleya Institute and marketed abroad by the Russian Direct Investment Fund (RDIF), is a two-dose […] Continue reading -> COVID-19 Vaccine Rollout Halted in Parts of South Africa Due to Civil Unrest 13/07/2021 Chandre Prince JOHANNESBURG – Violent unrest in South Africa has had a disastrous impact on the country’s healthcare and emergency services and has brought the COVID-19 vaccine roll-out to a near standstill in at least two provinces, as the country continues to battle with a third wave of the pandemic. On Tuesday, the national health department temporarily […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
A New Partnership to Help Eliminate Complex and Persistent Malaria Vivax 14/07/2021 Chandre Prince Ethiopia, India, Indonesia, Papua New Guinea and Peru are set to benefit from a US$ 25 million investment by Unitaid into a new Partnership For Vivax Elimination (PAVE), which aims to help these countries eliminate Plasmodium vivax (P. Vivax) malaria. PAVE will also generate and consolidate evidence to support malaria-endemic countries in developing and implementing […] Continue reading -> Scale Up of Sputnik V Vaccine Production Through Agreement with Serum Institute 13/07/2021 Madeleine Hoecklin The Serum Institute of India (SII), the world’s largest vaccine manufacturer, is set to begin producing Russia’s Sputnik V COVID-19 vaccine in September, paving the way to scale up globally available COVID vaccines. The Sputnik V vaccine, produced by Moscow’s Gamaleya Institute and marketed abroad by the Russian Direct Investment Fund (RDIF), is a two-dose […] Continue reading -> COVID-19 Vaccine Rollout Halted in Parts of South Africa Due to Civil Unrest 13/07/2021 Chandre Prince JOHANNESBURG – Violent unrest in South Africa has had a disastrous impact on the country’s healthcare and emergency services and has brought the COVID-19 vaccine roll-out to a near standstill in at least two provinces, as the country continues to battle with a third wave of the pandemic. On Tuesday, the national health department temporarily […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Scale Up of Sputnik V Vaccine Production Through Agreement with Serum Institute 13/07/2021 Madeleine Hoecklin The Serum Institute of India (SII), the world’s largest vaccine manufacturer, is set to begin producing Russia’s Sputnik V COVID-19 vaccine in September, paving the way to scale up globally available COVID vaccines. The Sputnik V vaccine, produced by Moscow’s Gamaleya Institute and marketed abroad by the Russian Direct Investment Fund (RDIF), is a two-dose […] Continue reading -> COVID-19 Vaccine Rollout Halted in Parts of South Africa Due to Civil Unrest 13/07/2021 Chandre Prince JOHANNESBURG – Violent unrest in South Africa has had a disastrous impact on the country’s healthcare and emergency services and has brought the COVID-19 vaccine roll-out to a near standstill in at least two provinces, as the country continues to battle with a third wave of the pandemic. On Tuesday, the national health department temporarily […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Rollout Halted in Parts of South Africa Due to Civil Unrest 13/07/2021 Chandre Prince JOHANNESBURG – Violent unrest in South Africa has had a disastrous impact on the country’s healthcare and emergency services and has brought the COVID-19 vaccine roll-out to a near standstill in at least two provinces, as the country continues to battle with a third wave of the pandemic. On Tuesday, the national health department temporarily […] Continue reading -> Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Leading COVID Vaccines Linked to Rare Side Effects 13/07/2021 Madeleine Hoecklin The single-dose Johnson & Johnson COVID-19 vaccine could lead to an increased risk of a rare neurological condition, warned the US Food and Drug Administration (FDA) on Monday, adding it to the list of possible side effects. This comes along with a series of new reports on the side effects associated with the leading COVID-19 […] Continue reading -> WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Lambasts Pfizer, Moderna & Rich Countries for Planning COVID Vaccine ‘Boosters’ – While Billions Wait for First Jab 12/07/2021 Elaine Ruth Fletcher WHO’s Director General Dr Tedros Adhanom Ghebreyesus slammed plans by Pfizer and Moderna, as well as a handful of rich countries, to begin offering ‘booster’ COVID vaccines to some groups of people – saying that the world has evolved a “dangerous” two-tiered system of vaccinations, driven by greed instead of enlightened self-interest. “It’s becoming a […] Continue reading -> Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Chinese Sinopharm and Sinovac Vaccines to Replenish Global COVAX Facility Supplies 12/07/2021 Editorial team Gavi, the Vaccine Alliance has signed advanced purchase agreements (APAs) with Sinopharm and Sinovac, Chinese biotech firms, to immediately begin supplying the global COVAX Facility with 110 million doses of COVID-19 vaccines, the agency announced on Monday. The agreements come as the Delta variant, first identified in India and classified as a WHO variant of […] Continue reading -> New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Global Recommendations for Human Genome Editing may Improve Use to Cure and Treat Diseases 12/07/2021 Madeleine Hoecklin Human genome editing has great potential to improve health and serve as a tool for public health, according to two landmark WHO reports, the world’s first to issue global recommendations on the safe, effective, and ethical use of human genome editing. “These new reports from WHO’s Expert Advisory Committee represent a leap forward for this […] Continue reading -> Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Lambda, the Newest WHO Variant of Interest, is Now in 29 Countries 09/07/2021 Raisa Santos The Lambda variant has now been found in 29 different countries, seven of them in Latin America and it is the dominant strain in Peru. The Lambda variant, or the C.37 strain, designated a variant of interest by the WHO on 15 June 2021, was first identified in Peru in August 2020. It is widespread […] Continue reading -> 15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
15 European Countries Recognize India’s Covishield Vaccine for EU Travel Pass; Only 10 Adopt All WHO-Approved Jabs 08/07/2021 Svĕt Lustig Vijay & Elaine Ruth Fletcher Nearly half of the 31 European nations using the European Union’s new digital COVID travel certificate have recognized the India-made version of the AstraZeneca vaccine, Covishield, alongside its European-made counterpart, Vaxzevria, an analysis by Health Policy Watch has revealed. But other major countries, including France, Poland, and Italy, seem to be holding out, authorizing only […] Continue reading -> Posts navigation Older postsNewer posts